Sodium Thiosulphate Not Much Help for Calciphylaxis in CKD
(MedPage Today) -- Credit: Niels Olson Intravenous sodium thiosulphate flopped for treating calciphylaxis in people with chronic kidney disease (CKD), researchers reported. In a systematic review and meta-analysis, there was no significant... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 26, 2023 Category: Dermatology Source Type: news

Make the Diagnosis: When the Sun, Physical Exertion, and Medications Team Up Against You
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 24, 2023 Category: Dermatology Source Type: news

Responses to PD-1 Blockade Approach 90% in Rare Melanoma
(MedPage Today) -- ORLANDO -- Exceedingly high response rates were seen with pembrolizumab (Keytruda) in patients with unresectable metastatic desmoplastic melanoma, according to results from the SWOG S1512 phase II trial presented here. Among... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 17, 2023 Category: Dermatology Source Type: news

Personalized Cancer Vaccine Boosts Recurrence-Free Survival in Melanoma
(MedPage Today) -- ORLANDO -- Adding a personalized cancer vaccine to anti-PD-1 immunotherapy for resectable melanoma led to a 44% improvement in recurrence-free survival (RFS) versus immunotherapy alone, according to a study reported here.... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 17, 2023 Category: Dermatology Source Type: news

Oral Drug Improves Sunlight Tolerance in Genetic Photosensitivity Disorders
(MedPage Today) -- Patients with severe genetically driven photosensitivity had significant improvement in sunlight tolerance when treated with the oral melanocortin 1 receptor agonist dersimelagon, a randomized placebo-controlled trial showed... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 13, 2023 Category: Dermatology Source Type: news

Diabetes Patient Develops Large Blisters, Macules on Lower Leg
(MedPage Today) -- Is infection, injury, or diabetic dermopathy responsible? (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 10, 2023 Category: Dermatology Source Type: news

Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosis
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 27, 2023 Category: Dermatology Source Type: news

At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks
(MedPage Today) -- NEW ORLEANS -- Almost 40% of patients with molluscum contagiosum, some with dozens of lesions, had complete or near-complete clearance after 12 weeks of nitric oxide-releasing gel, the largest-ever randomized trial of the skin... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 23, 2023 Category: Dermatology Source Type: news

Outlook for Itchy Prurigo Nodularis Continues to Improve With IL-31 Antagonist
(MedPage Today) -- NEW ORLEANS -- An investigational antibody targeting interleukin (IL)-31 in prurigo nodularis significantly reduced itch, skin lesions, and sleep disturbance in a phase III trial. More than half of patients treated with nemolizumab... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 22, 2023 Category: Dermatology Source Type: news

Durable Vitiligo Responses With Topical Ruxolitinib
(MedPage Today) -- NEW ORLEANS -- Patients who discontinued topical ruxolitinib (Opzelura) for vitiligo retained new pigmentation for as long as a year, according to a study of planned withdrawal. Almost 40% of patients maintained their response... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 21, 2023 Category: Dermatology Source Type: news

High Rates of Psoriasis Clearance With Investigational TYK2 Inhibitor
(MedPage Today) -- NEW ORLEANS -- As many as a third of patients with moderate or severe psoriasis had complete clearance within 12 weeks with an investigational oral tyrosine kinase 2 (TYK2) inhibitor, a small randomized trial showed. From... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 21, 2023 Category: Dermatology Source Type: news

Cases of Bald Spots After Regular Use of Detangling Hairbrushes
(MedPage Today) -- A report of three cases of trichomalacia in young women (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 20, 2023 Category: Dermatology Source Type: news

Response Rates in Hidradenitis Suppurativa Continue to Climb With New Therapies
(MedPage Today) -- NEW ORLEANS -- A trio of novel therapies produced clinically significant improvements in 40% to 70% of patients with moderate to severe hidradenitis suppurativa (HS), according to data reported here. Izokibep, a novel interleukin... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 20, 2023 Category: Dermatology Source Type: news

Another Win for a JAK Inhibitor in Alopecia Areata
(MedPage Today) -- NEW ORLEANS -- Patients with severe alopecia areata had dramatic hair regrowth at 6 months with an investigational Janus kinase (JAK) inhibitor, according to a study reported here. Almost 40% of patients had at least 80% scalp... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 20, 2023 Category: Dermatology Source Type: news

Biologic Switch Revs Up Response in Plaque Psoriasis
(MedPage Today) -- NEW ORLEANS -- Plaque psoriasis that responded inadequately to an interleukin (IL)-17 inhibitor often had deep and durable responses after switching to the IL-23 inhibitor risankizumab (Skyrizi), a long-term prospective trial... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 19, 2023 Category: Dermatology Source Type: news